PharmaCyte Biotech, Inc.

Pharmacyte Biotech, Inc.

Biotechnology • Healthcare • Las Vegas, NV, United States • PMCB (NCM)

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

917 595 2850 3960 Howard Hughes Parkway, Las Vegas, NV 89169, United States

Stock Performance (90 Days)

Data through Dec 30, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

PharmaCyte Biotech successfully monetizes Femasys stake - The Pharma Letter
The Pharma Letter • Dec 7
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
StocksToTrade • Dec 4
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
MSN • Nov 25
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
Investing.com • Nov 25
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Investing News Network
Investing News Network • Sep 12

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has PharmaCyte Biotech, Inc. had layoffs?
No layoff events have been recorded for PharmaCyte Biotech, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does PharmaCyte Biotech, Inc. have?
PharmaCyte Biotech, Inc. has approximately 2 employees.
What industry is PharmaCyte Biotech, Inc. in?
PharmaCyte Biotech, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is PharmaCyte Biotech, Inc. a publicly traded company?
Yes, PharmaCyte Biotech, Inc. is publicly traded under the ticker symbol PMCB on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is PharmaCyte Biotech, Inc. headquartered?
PharmaCyte Biotech, Inc. is headquartered in Las Vegas, NV, United States at 3960 Howard Hughes Parkway, Las Vegas, NV 89169, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.